Last reviewed · How we verify
Human Rabies Immune Globulin — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
Human Rabies Immune Globulin (Human Rabies Immune Globulin) — Queen Saovabha Memorial Institute.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Human Rabies Immune Globulin TARGET | Human Rabies Immune Globulin | Queen Saovabha Memorial Institute | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Human Rabies Immune Globulin CI watch — RSS
- Human Rabies Immune Globulin CI watch — Atom
- Human Rabies Immune Globulin CI watch — JSON
- Human Rabies Immune Globulin alone — RSS
Cite this brief
Drug Landscape (2026). Human Rabies Immune Globulin — Competitive Intelligence Brief. https://druglandscape.com/ci/human-rabies-immune-globulin. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab